Fair-Value Report — LIT Life Holdings Ltd. (8079.HK)

Insider Signal

Signal assessment — PROCEED: LIU HAOYU appears to be an existing substantial shareholder (previously ~7.3%) who chose to cross the 10% threshold — a strategically significant threshold that confers blocking power on certain GEM resolutions. The trade size (~HKD 850,000) is material for a stock with a HKD 24M market cap. However, the stock sold off 24% intraday from the apparent purchase price (0.85 → 0.65 on 11 Aug), which partially undermines the near-term conviction narrative. The identity and strategic intent of LIU HAOYU could not be independently confirmed from public director/officer filings.

Verified Snapshot

Share count note: The FY2026 balance sheet (March 31, 2026) reported 31.12M shares and equity of HKD 25.22M, implying book value of HKD 0.810/share. Current shares outstanding are 36.64M, implying ~5.52M new shares issued post year-end (18% dilution). Assuming these were issued at ~HKD 0.70–0.85, estimated adjusted equity is ~HKD 28–30M; adjusted book value/share ~HKD 0.72. All per-share figures in this report use 36.64M shares and HKD 0.72 book unless otherwise stated.

Business Overview

LIT Life Holdings Ltd. (formerly Wisdomcome Group Holdings Ltd.) is a GEM-board micro-cap with two operating segments:

• Grocery Retail & Wholesale (~primary): Specialty snacks, gourmet food, hormone-free frozen food, seasonal fruit, ready-to-eat products, pet products, and health supplements. Sells both wholesale and retail in Hong Kong.
• Money Lending: Licensed money-lending to individuals and businesses in Hong Kong.

The company operates with approximately 42 employees. Revenue has declined at a –17% CAGR over three years (FY2022: HKD 98M → FY2026: HKD 45.5M), though FY2026 showed the first YoY revenue growth (+9.5%) and dramatic loss narrowing (net loss improved 92% to HKD –3.5M). The business has been shrinking toward a more focused core. Segment-level profit contributions are not separately disclosed in available data.

*36.64M current; 31.12M at FY2026 year-end. FY2024 loss includes likely impairment charges. Sources: StockAnalysis.com, Stockopedia.

Valuation

Methodology

LIT Life is a loss-making, mixed-model micro-cap. FCF-based DCF is not applicable given continued losses and highly uncertain trajectory. The appropriate primary anchor is Price-to-Book (P/B), using adjusted book value to reflect post-year-end share issuances. A revenue multiple (P/Sales) serves as a secondary check. Stockopedia reports a P/FCF of ~6.3x at a price of ~HKD 0.84, implying ~HKD 0.134/share of free cash flow; at HKD 0.65 this implies P/FCF of ~4.9x. While positive FCF is encouraging, it cannot be independently verified without segment cash-flow data and should be treated as indicative.

Adjusted Book Value Estimate

• FY2026 year-end equity: HKD 25.22M (March 31, 2026)
• Post-year-end share issuance (~5.52M shares at est. HKD 0.75 avg): +HKD 4.1M
• Less estimated losses April–August 2026 (based on run-rate of ~HKD 0.7M/qtr): –HKD 1.0M
• Estimated current equity: ~HKD 28.3M → ~HKD 0.77/share

These equity estimates are unaudited and subject to material uncertainty. The next interim results (likely September 2026) will provide verified figures.

Scenario Table

Median (base) fair value: HKD 0.77. Current price of HKD 0.65 implies an 18% discount to base-case book value. The discount is modest and does not fully compensate for the risks below. The stock's 16% average weekly volatility means the fair-value range is wide. The asymmetry (42% upside vs 40% downside) is roughly balanced — not an obviously compelling risk/reward.

Reverse Read

At HKD 0.65, the market implies a P/B of ~0.84× on our adjusted book estimate. For a money-lending + grocery operator with a–17% revenue CAGR over 3 years and ongoing losses, this is a mild discount that reflects real risk but not deep pessimism. The price embeds no expectation of near-term profitability. A path to breakeven (plausible given the 92% loss improvement in FY2026) would justify at least 1.0–1.2× book (HKD 0.77–0.92). Upside is real but not dramatic.

Peer Comparison

Peer data is approximate; no direct listed comparables at this exact business mix and size. HK GEM micro-cap peer data sourced from general sector knowledge; treat as directional only.

Conclusion

Rating: Hold / Speculative.

The LIU HAOYU purchase is assessed as a genuine insider signal — a real buyer crossing the 10% strategic threshold in a micro-cap, spending ~HKD 850,000. However, three factors temper conviction:

1. Price action suggests the signal may have been prematurely priced. The stock hit HKD 0.855 intraday on 11 August (consistent with the DI purchase price) and closed at HKD 0.65 — a 24% single-day reversal on 1.16M shares (~3% of the float). Insiders buying near 52-week highs in thinly traded GEM stocks is a pattern requiring caution.
2. Chronic dilution is a structural problem. Shares have grown from 12M (FY2022) to 36.64M (current) — a 3× dilution in four years. Even if the business improves, the per-share value accrual is blunted. An 18% share increase in the past year alone is significant.
3. Revenue trajectory is ambiguous. FY2026 showed the first revenue uptick (+9.5%) after four years of decline. Whether this is a genuine inflection or a one-year blip is unclear without segment detail.

On the positive side: the 92% loss improvement is striking, cash is positive (net cash HKD 2.6M), the P/B discount at 0.65 (0.84×) provides some floor, and the FCF figure (if accurate) would imply a very cheap P/FCF of ~5×. If FY2027 shows continuing improvement toward profitability, the stock could re-rate toward HKD 0.90+.

For investors already holding: no reason to add at the post-DI price but no urgent exit either. For new money: wait for interim results (est. September/October 2026) to confirm the FY2026 trend is continuing before committing.

Key Risks

• Dilution risk (HIGH): 3× share count growth in 4 years; further placings likely if losses continue. Each new issuance transfers value from existing holders.
• Revenue concentration & decline: Three-year CAGR of –17%. Recovery in FY2026 needs to be sustained.
• Money lending credit risk: Loan book quality is not separately disclosed; a spike in defaults could rapidly erode book value.
• Micro-cap liquidity: Typical daily turnover ~HKD 50,000–100,000; any position of size is illiquid. The 1.16M shares on 11 August (~HKD 750K) were exceptionally high.
• GEM board governance: GEM stocks are subject to lighter market infrastructure; financial controls and reporting quality should be assumed less robust than main-board issuers.
• Buyer intent opaque: LIU HAOYU's strategic intent (passive investment vs. corporate control vs. concert-party buildup) could not be confirmed from available public filings.
• Unverified DI form: The specific HKEX DI filing was not directly accessed (DION system unavailable). The possibility that the transaction is a placing-at-a-discount coded as 1103 (off-exchange) cannot be entirely excluded.
• High volatility: 16% average weekly price swing makes entry timing difficult and risk management challenging.

Sources

• StockAnalysis.com — 8079.HK income statement, balance sheet (accessed 13 Aug 2026)
• Stockopedia — HKG:8079 price, P/B, P/FCF, shares outstanding (accessed 13 Aug 2026)
• HKEX GEM Daily Quotations — e_G260811.htm, e_G260812.htm (HKEX official daily data)
• Simply Wall St — market cap, dilution data (via web search, 13 Aug 2026)
• HKEX DION DI System — searched but system returned "temporarily unavailable" on 13 Aug 2026
• Internal hkex-scanner automated pre-screening (reason-code 1101/1103 classification)